Sernova Biotherapeutics Inc (SEOVF)
Sernova Biotherapeutics Inc is a Canada-based clinical-stage biotechnology company listed on OTC Markets as common stock under ticker SEOV.F. The company focuses on regenerative medicine and is developing its proprietary Cell Pouch platform, a bio-hybrid organ system designed to support the function and longevity of therapeutic cells while also allowing for retrieval. The Cell Pouch is intended to create a vascularized environment that can help replicate natural body functions. The company was previously known as Sernova Corp. and adopted its current name in February 2025. Sernova Biotherapeutics Inc is headquartered in Mississauga, Canada.
Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ
Jump directly to the stock analysis sections supported by the latest available data.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Next Earnings Date | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-SEOV.F
|
$0.068
|
-14.7% Downside
|
Fair
|
Not available
|
Not available
|
Weak
|
0.0%
|
December 18, 2026
|
28.299 M
|
40.011 M
|
4.6%
|
89.2%
|
-1,881.3
|
42.9%
|
